2,066
Views
11
CrossRef citations to date
0
Altmetric
Original Articles: Rheumatoid Arthritis

Long-term efficacy and safety of certolizumab pegol in Japanese rheumatoid arthritis patients who could not receive methotrexate: 52-week results from an open-label extension of the HIKARI study

, , , , , , , , , & show all
Pages 725-733 | Received 06 Aug 2013, Accepted 11 Nov 2013, Published online: 29 Dec 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Ioannis Mykoniatis, Stavros Tsiakaras, Michael Samarinas, Anastasios Anastasiadis, Evangelos N Symeonidis & Petros Sountoulides. (2022) Monoclonal Antibody Therapy for the Treatment of Interstitial Cystitis. Biologics: Targets and Therapy 16, pages 47-55.
Read now
Tsutomu Takeuchi, Kazuhiko Yamamoto, Hisashi Yamanaka, Naoki Ishiguro, Yoshiya Tanaka, Katsumi Eguchi, Akira Watanabe, Hideki Origasa, Mariko Kobayashi, Toshiharu Shoji, Osamu Togo, Nobuyuki Miyasaka & Takao Koike. (2016) analysis showing better clinical response with the loading dose of certolizumab pegol in Japanese patients with active rheumatoid arthritis. Modern Rheumatology 26:4, pages 473-480.
Read now
Vicenç Torrente-Segarra, Ana Urruticoechea Arana, Amalia Sánchez-Andrade Fernández, Juan Víctor Tovar Beltrán, Alejandro Muñoz Jiménez, Anna Martínez-Cristóbal, José Antonio González Ferrández, Manuel Fernández Prada, Noelia Vázquez Fuentes, Hèctor Corominas, Sílvia García-Díaz, Asunción Acosta Pereira, José Miguel Ruiz Martín, José Ramón Lamua Riazuelo, Rosa Expósito Moliner, Desireé Ruiz Vilchez, Raúl Veiga Cabello, Jesús Carlos Fernández, José Raúl Noguera Pons, Noemí Patricia Garrido Puñal, Pedro Giralt Celiméndiz, Raúl Cortés Verdú, Angel Aragón Díez, Carlos Tomás Roura, Concepción Moll Turudi, Delia Taverner Torrent, Felipe Joaquín Rivas Santirso, Juan José Lerma Garrido, Rosa García Portales, Sergi Ordoñez Palau, Silvia Paredes González-Albo, Antonio Gracia Pérez, Arantxa Conesa Mateos, Jaime Calvo Alén, Jenaro Graña Gil, María Pilar Navarro Alonso & María Jesús Martínez Blasco. (2016) study: Assessment of 12-month efficacy and safety of 168 certolizumab PEGol rheumatoid arthritis-treated patients from a Spanish multicenter national database. Modern Rheumatology 26:3, pages 336-341.
Read now
Tsutomu Takeuchi, Kazuhiko Yamamoto, Hisashi Yamanaka, Naoki Ishiguro, Yoshiya Tanaka, Katsumi Eguchi, Akira Watanabe, Hideki Origasa, Toshiharu Shoji, Nobuyuki Miyasaka & Takao Koike. (2015) Early response to certolizumab pegol predicts long-term outcomes in patients with active rheumatoid arthritis: results from the Japanese studies. Modern Rheumatology 25:1, pages 11-20.
Read now

Articles from other publishers (7)

Yoshiya Tanaka, Masafumi Kawanishi, Megumi Nakanishi, Hironori Yamasaki & Tsutomu Takeuchi. (2022) Efficacy and safety of anti-TNF multivalent NANOBODY® compound ‘ozoralizumab’ without methotrexate co-administration in patients with active rheumatoid arthritis: A 52-week result of phase III, randomised, open-label trial (NATSUZORA trial). Modern Rheumatology.
Crossref
Hideto Kameda, Keiichiro Nishida, Toshihiro Nanki, Akira Watanabe, Yukiya Oshima & Shigeki Momohara. (2022) Safety and effectiveness of certolizumab pegol in Japanese patients with rheumatoid arthritis: Results from a 24-week post-marketing surveillance study. Modern Rheumatology.
Crossref
Yune-Jung Park, Ana Maria Gherghe & Desirée van der Heijde. (2020) Radiographic progression in clinical trials in rheumatoid arthritis: a systemic literature review of trials performed by industry. RMD Open 6:2, pages e001277.
Crossref
Vicente Ruiz Garcia, Amanda Burls, Juan B Cabello, Paloma Vela Casasempere, Sylvia Bort-Marti & José A Bernal. (2017) Certolizumab pegol (CDP870) for rheumatoid arthritis in adults. Cochrane Database of Systematic Reviews 2017:9.
Crossref
Hideto KAMEDA, Keiichiro NISHIDA, Toshihiro NANNKI, Akira WATANABE, Yukiya OSHIMAShigeki MOMOHARA. (2017) Safety and effectiveness of certolizumab pegol in patients with rheumatoid arthritis: Interim analysis of post-marketing surveillance. Japanese Journal of Clinical Immunology 40:3, pages 196-205.
Crossref
Vicente Ruiz Garcia, Paresh Jobanputra, Amanda Burls, Juan B Cabello, Paloma Vela Casasempere, Sylvia Bort-Marti & Francis JB Kynaston-Pearson. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Peter Y Shane & Sadayoshi Onodera. (2014) Novel TNF^|^alpha; inhibitor, certolizumab pegol. Drug Delivery System 29:2, pages 160-165.
Crossref